Investor Presentaiton slide image

Investor Presentaiton

8 00 Our leadership team encompasses decades of collective experience and a common commitment to biosimilars 24 28 ROBERT WESSMAN Chief Executive Officer HAFRUN FRIDRIKSDOTTIR Chief Operating Officer M gsk Alvogen teva Actavis Allergan M Actavis 20 A AZTIQ Lotus ADALVO teva 20 JOSEPH E. MCCLELLAN Chief Scientific Officer Wyeth Pfizer 20 17 JOEL MORALES ANIL OKAY Chief Financial Officer Chief Commercial Officer alvotech 20 TANYA ZHAROV General Counsel & Head of Legal MERCK KPMG A AZTIQ ABDIIBRAHIM deCODE genetics PAR PHARMACEUTICAL SANOFI RICHTER-HELM) Alvogen ADALVO pwc GIEDRIUS ZUNDA Chief Technical Officer 25 SANDRA CASACA Chief Quality Officer 20 PHILIP CARAMANICA Chief IP Counsel, Deputy General Counsel Z-Biotech Consulting AMGEN abbvie ll Bristol Myers Squibb NORTHWAY® BIOTECH ATARA BIO SANDOZA Novartis Division Synthon CardinalHealth 20 30 MING LI Chief Strategy Officer ROSE-MARIE OHLSSON Chief Information Officer ALPHARMA. M Actavis Alvogen A AZTIQ ●sobi SEB rare strength © ALVOTECH. ALL RIGHTS RESERVED
View entire presentation